Could cord blood injections halt vision loss in dry AMD?
NCT ID NCT05706896
Summary
This pilot study is testing whether injections of umbilical cord blood platelet-rich plasma into the eye can slow or stop the progression of dry age-related macular degeneration (AMD). Researchers will enroll 36 participants aged 65+ with bilateral dry AMD to compare the injections against a sham procedure. The main goal is to see if the treatment can stabilize the area of retinal damage and potentially improve vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRome, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.